Drug conversion in Alzheimer's Disease

 
   Lead Investigator:    Raiyan Khan
   Institution      :    Stanford University
   E-Mail           :    rrkhan@stanford.edu
   Proposal ID      :    580



   Proposal Description:
   The focus of this study is to understand the effect of sex, APOE genotype, and    medication use on the conversion risk from healthy controls to MCI or AD, as      well as from MCI to AD. We would like to apply survival analysis to the data      set in order to elucidate whether certain drugs confer a protective effect. The   data set will be corrected for a number of socioeconomic factors that we have     requested in the data package. Analysis will be completed using the cox           proportional hazard model.